What Exir Pharmaceuticals does

Exir Pharmaceuticals (شرکت داروسازی اکسیر) is a publicly traded Iranian pharmaceutical manufacturer founded in 1988 and headquartered in Tehran, with its main production facility located on a 36-hectare site in Borujerd, Lorestan Province. The company operates four specialized production divisions — Solids (tablets), Liquids (syrups), Antibiotics (cephalosporins), and Sterile (injectables) — manufacturing over 170 pharmaceutical products across 17+ therapeutic categories including cardiovascular, endocrine, anti-infective, central nervous system, respiratory, gastrointestinal, pain management, and nutritional supplements.

The business operates on a sales-led B2B model, distributing products through Iran's domestic pharmacy networks, hospital procurement channels, and tender-based government healthcare contracts. It also provides contract manufacturing services for other Iranian pharmaceutical companies including Mahyadc, Dr. Abidi, Aria Tinagen, Kabel, Homa Pharmed, and Zagros Pharmed. Pricing is subject to regulation by the Iran Food and Drug Administration. Exir is a subsidiary of Tamin Pharmaceutical Investment Company (TPICO), which is itself part of Iran's Social Security Organization (Shasta). The company has 501-1,000 employees and holds the National Green Industry Medal (تندیس ملی صنعت سبز) and was named Health-Oriented Employer of Lorestan Province in 1404 (2025).

Recent activity includes leadership transitions under TPICO oversight (Dr. Assem Abdullahpour appointed August 2025; Dr. Meysam Nourmohammadi appointed April 2026), expanded financial relationships with major Iranian banks including Export Development Bank of Iran for export-oriented operations, and an ongoing broad product portfolio expansion.

Name

Exir Pharmaceuticals

Legal name

شرکت داروسازی اکسیر (Exir Pharmaceutical Company)

Website

https://exir.co.ir

Company type

Public

Founded year

1988

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Exir Pharmaceuticals is an Iranian pharmaceutical manufacturer operating a 36-hectare factory in Borujerd with four production divisions producing 170+ drugs across 17 therapeutic categories, supplying Iran's domestic pharmacies, hospitals, and government health sector under TPICO/Social Security ownership.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF), Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

Keywords

• Pharmaceutical manufacturing
• Generic pharmaceuticals
• Cephalosporin antibiotics
• Sterile injectables
• Oral solid dosage

Headquarters

HQ city

Tehran

HQ country

Iran

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Exir Pharmaceuticals generates revenue through the manufacture and sale of pharmaceutical products across 17+ therapeutic categories including antibiotics, cardiovascular, gastrointestinal, endocrine, CNS, respiratory, and injectable medications. The company also produces contract manufacturing products for other pharmaceutical companies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Exir Pharmaceuticals manufactures and supplies generic and branded pharmaceutical finished dosage forms — tablets, syrups, cephalosporin antibiotics, and sterile injectables — across cardiovascular, endocrine, anti-infective, CNS, respiratory, gastrointestinal, nephrology, anesthesia, and supplement categories. Products are sold to Iranian hospitals, pharmacies, and government health agencies through tenders and direct sales, with additional contract manufacturing services for partner pharmaceutical companies.

Product overview

Exir Pharmaceuticals is a major Iranian pharmaceutical company operating a 36-hectare manufacturing facility with four production divisions: solids/tablets, liquids/syrups, antibiotics (cephalosporins), and sterile injectables. The company offers an extensive portfolio of over 50 oral products, 20 injectable products, and 100+ supplement products. The product portfolio includes branded pharmaceutical products across therapeutic categories including cardiovascular medications (such as Bisopex for bisoprolol, Clopidex for clopidogrel, Roxir for rosuvastatin), antibiotics (Klarexir for clarithromycin, Afloxir for ofloxacin, Cefixime-based products like Loprax), diabetes treatments (Diabetoz for sitagliptin, various insulin formulations under Lansulin brand including regular, NPH, and premixed 70/30), gastrointestinal drugs (Omeprazole, Famotidine, Lactulose), neurological medications (Gabapentin, Fluoxetine, Glatiramer under Glaxir brand), respiratory products (Salbutamol, Ketotifen under Zexifen brand, Fexofenadine under Sad-OF brand), injectable antibiotics (various cephalosporins including Ceftriaxone, Ceftazidime, Cefepime, Cefotaxime), and various other pharmaceutical preparations including vitamins, corticosteroids, antihistamines, and contrast media. The company manufactures both generic and branded pharmaceutical products in various dosage forms.

Differentiator

Problem solved

Functional benefit

Products and services

• Solids - Tablets (جامدات - قرص ها) Tablet dosage form production facility at Exir's Borujerd plant. Manufactures the company's wide range of oral solid pharmaceutical products including cardiovascular, endocrine, CNS, gastrointestinal, anti-infective, and supplement tablets for the Iranian domestic market.
• Liquids - Syrups (مایعات - شربت ها) Liquid and syrup dosage form production facility. Produces pediatric and adult liquid medications, including cold and flu preparations (Exakid, Exacold) and antibiotic suspensions (Zimexir Suspension), distributed through Iran's pharmacy networks.
• Antibiotics - Cephalosporins (آنتی بیوتیک - سفالسپورین) Cephalosporin antibiotic production facility. Manufactures oral and injectable cephalosporin antibiotics such as Ceftriaxone, Ceftazidime, Cefepime, Cefotaxime, Cefixime (Loprax), and Cefazolin for treatment of bacterial infections across hospital and outpatient settings in Iran.
• Sterile - Injectables (استریل - تزریقی) Sterile injectable dosage form production facility. Produces small- and large-volume injectable pharmaceuticals including vasopressors, anesthetics, oncology-supportive therapies, insulins, and antibiotic injectables used in hospital critical-care settings.
• Atorvastatin (آتورواستاتین) Statin medication in 10/20/40 mg tablets for lowering cholesterol and reducing cardiovascular risk. Sold through Iranian pharmacies for the treatment of hypercholesterolemia and prevention of cardiovascular events.
• Roxir 40 (رزواکسیر 40) Exir brand of Rosuvastatin 40mg, an HMG-CoA reductase inhibitor that reduces cholesterol synthesis in the liver. Used in Iranian patients for hypercholesterolemia management and cardiovascular risk reduction.
• Bisopex (بیزوپکس) Exir brand of Bisoprolol beta-blocker for treatment of hypertension and heart conditions. Distributed through Iranian retail and hospital pharmacies.
• Clopidex (کلوپیدکس) Exir brand of Clopidogrel antiplatelet agent for prevention of cardiovascular events including stent thrombosis, myocardial infarction, and stroke.
• Diabetoz (دیابتوز) Exir brand of Sitagliptin 100mg, a DPP-4 inhibitor for oral treatment of Type 2 diabetes. Sold through Iranian pharmacies.
• Lansulin (لانسولین) insulin range Exir's branded insulin product line covering regular (Lansulin R), NPH/isophane (Lansulin N), and premixed 70/30 formulations in vials and cartridges for diabetes treatment.
• Emifloz (امیفلوز) Exir brand of Empagliflozin 25mg, an SGLT2 inhibitor for Type 2 diabetes and heart failure treatment. Distributed through Iranian pharmacies.
• Sevagel (سواژل) Sevelamer hydrochloride 800mg tablet for phosphate control in patients with chronic kidney disease on dialysis. Provided to hospital and outpatient renal patients in Iran.
• Exilamer (اکسیلامر) Sevelamer carbonate 800mg tablet for phosphate binding and control in renal patients. Distributed through Iranian hospital and pharmacy channels.
• Omeprazole (امپرازول) Proton pump inhibitor for treatment of acid-related gastrointestinal disorders including GERD, peptic ulcer disease, and Zollinger-Ellison syndrome.
• Famotidine (فاموتیدین) H2 receptor antagonist 40mg tablet for gastric acid reduction and ulcer treatment. Distributed through Iranian pharmacies.
• Ceftriaxone (سفتریاکسون) Third-generation cephalosporin antibiotic 500mg injection for treatment of various bacterial infections including respiratory, urinary, skin, and intra-abdominal infections. Used in Iranian hospitals.
• Ceftazidime (سفتازیدیم) Third-generation cephalosporin antibiotic 1000mg injection for treatment of severe bacterial infections, including pseudomonal infections, in hospital settings.
• Cefepime (سفپیم) Fourth-generation cephalosporin antibiotic 1000mg injection for treatment of serious bacterial infections including those resistant to other cephalosporins. Distributed to Iranian hospitals.
• Loprax (لوپراکس) Exir brand of Cefixime antibiotic 200/400mg tablets for treatment of respiratory and urinary tract infections. Sold through Iranian pharmacies.
• Klarexir (کلاراکسیر) Exir brand of Clarithromycin 500mg, a macrolide antibiotic for treatment of respiratory, skin, and Helicobacter pylori infections.
• Afloxir (افلوکسیر) Exir brand of Ofloxacin 300mg, a fluoroquinolone antibiotic for treatment of bacterial infections. Distributed through Iranian pharmacies.
• Ciprofloxacin (سیپروفلوکساسین) Fluoroquinolone antibiotic 500mg tablet for treatment of various bacterial infections including urinary, respiratory, and gastrointestinal infections.
• Supranem (سوپرانم) Exir brand of Imipenem/Cilastatin carbapenem antibiotic injection for treatment of serious mixed bacterial infections in hospitalized patients.
• Meropenem (مرونم) Carbapenem antibiotic 1000mg injection for treatment of serious nosocomial infections including intra-abdominal, meningitis, and severe respiratory infections in hospital settings.
• Fluoxetine (فلوکستین) SSRI antidepressant for treatment of depression, anxiety disorders, and obsessive-compulsive disorder. Sold through Iranian pharmacies.
• Gabapentin (گاباپنتین) Anticonvulsant 300mg for seizure control and management of neuropathic pain. Distributed through Iranian retail and hospital pharmacies.
• Glaxir (گلکسیر) Exir brand of Glatiramer acetate immunomodulator 40mg injection for treatment of multiple sclerosis, provided to Iranian hospital and specialty pharmacy patients.
• Zexifen (زکسیفن) Exir brand of Ketotifen antihistamine for management of allergic conditions including allergic rhinitis, asthma, and atopic dermatitis.
• Sad-OF (سد-آف) Exir brand of Fexofenadine 180mg, a non-sedating antihistamine for allergic rhinitis and chronic urticaria. Sold through Iranian pharmacies.
• Epinephrine (اپی نفرین) Epinephrine injection for emergency treatment of severe allergic reactions (anaphylaxis), cardiac arrest, and severe asthma attacks in hospital and emergency settings.
• Ketamine (کتامین) General anesthetic injection for short surgical procedures, procedural sedation, and pain management in hospital and ambulatory surgical settings.
• Norepinephrine (نوراپی نفرین) Vasopressor injection for management of hypotensive states following cardiac surgery, septic shock, and acute hypotensive emergencies in ICU settings.
• Compifen (کامپی فن) Combination analgesic containing acetaminophen, caffeine, and ibuprofen for management of headache and migraine pain.
• Acetaminophen/Codeine combination (استامینوفن کدئین) Combination analgesic containing acetaminophen and codeine for management of moderate to severe pain under medical supervision.
• Vasopressin (آمپول وازوپرسین) Hormone injection used as an antidiuretic and vasopressor for treatment of diabetes insipidus, septic shock, and variceal hemorrhage in hospital settings.
• Aciclovir (آسیکلوویر) Antiviral medication 500mg for treatment of herpes virus infections including herpes simplex, herpes zoster, and varicella-zoster.
• Zimexir Suspension (سوسپانسیون زیمکسیر) Antibiotic suspension in 100/200 mg formulations for pediatric infectious disease treatment. Distributed through Iranian pharmacies.
• Contract Manufacturing Services Third-party pharmaceutical contract manufacturing service offered by Exir to partner companies including Mahyadc, Dr. Abidi, Aria Tinagen, Kabel, Homa Pharmed, and Zagros Pharmed. Exir manufactures products under partner brands or supplies products utilizing its four GMP-compliant production divisions.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered minor.

• MahyadcminorStrategic or Co-development PartnerMahyadc is a pharmaceutical company that partners with Exir for contract manufacturing of pharmaceutical products. The partnership involves co-production arrangements where Exir manufactures products under the Mahyadc brand or supplies products.
• Dr. AbidiminorStrategic or Co-development PartnerDr. Abidi pharmaceutical company collaborates with Exir for contract manufacturing. Exir provides manufacturing capabilities for Dr. Abidi's product portfolio.
• Aria TinagenminorStrategic or Co-development PartnerAria Tinagen is a pharmaceutical company partnered with Exir for contract manufacturing arrangements.
• KabelminorStrategic or Co-development PartnerKabel pharmaceutical company partners with Exir for contract manufacturing of pharmaceutical products.
• Homa PharmedminorStrategic or Co-development PartnerHoma Pharmed is a pharmaceutical company that collaborates with Exir for contract manufacturing services.
• Zagros PharmedminorStrategic or Co-development PartnerZagros Pharmed partners with Exir for contract manufacturing arrangements in the pharmaceutical sector.

Scale indicators3 records

Recent moves6 records

Expansion highlights3 records

Emerging players

• Hikma Pharmaceuticals: Jordan-founded, London-listed specialty and generic pharmaceutical manufacturer with strong MENA presence. Comparable as a regional generics player with injectable, oral, and contract manufacturing capabilities.

Broad incumbents

• Cipla: One of the largest generic pharmaceutical manufacturers globally, with broad therapeutic coverage and large-scale manufacturing across multiple dosage forms including injectables and antibiotics. Comparable as a high-volume generics producer.
• Aurobindo Pharma: Indian-headquartered global generic manufacturer with significant sterile injectable and cephalosporin/antibiotic capabilities. Comparable in product mix (sterile injectables, antibiotics, oral solids) and large-scale manufacturing footprint.
• Tamin Pharmaceutical Investment Company (TPICO): Exir's parent holding and the largest pharmaceutical conglomerate in Iran, controlling multiple pharma manufacturers including Darou Pakhsh, Barakat, and Sobhan. Comparable as a portfolio operator in the same value chain with broader scope than Exir.

Regional players

• Julphar (Gulf Pharmaceutical Industries): One of the largest pharmaceutical manufacturers in the UAE/MENA region producing generics and branded products across multiple dosage forms. Comparable as a regional generic manufacturer serving Middle East markets with similar scale and product breadth.
• SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation): Leading Saudi Arabian pharmaceutical manufacturer producing generics and branded products. Comparable as a regional state-influenced generics producer with similar product portfolio and government-channel exposure.

Direct peers

• Barakat Pharmaceutical Company: Iranian pharmaceutical manufacturer under TPICO producing generics across multiple therapeutic categories. Directly comparable in product mix, domestic market focus, and parent-company alignment.
• Darou Pakhsh Pharma: Iran's largest pharmaceutical manufacturer and sister company to Exir under TPICO. Directly comparable as a large-scale domestic generics and specialty manufacturer with broad therapeutic coverage and contract manufacturing operations.
• Sobhan Oncology: TPICO-affiliated Iranian pharmaceutical manufacturer specializing in oncology and specialty products. Comparable as a domestic Iranian pharma operating under the same holding structure with hospital-channel sales focus.
• Darvash (Darvash Pejvak): Iranian pharmaceutical manufacturer producing generic drugs across multiple therapeutic categories for the domestic market. Comparable as a domestic Iranian generics peer competing in the same hospital and pharmacy channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/codevz2
• Facebookfacebook.com/Codevz
• LinkedInlinkedin.com/company/exir-pharmaceuticals-company

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Exir Pharmaceuticals